HEMAY PHARMA-B

54
----
Delay To be listed: Nov 16, 16:08:00

Financials

FY2025 Earnings

Financial report interval: 2024.12.31 - 2025.12.31

Overview: HEMAY PHARMA-B(00054) the EBIT is -143.73 M (-5.54%);the EPS is -0.358 (-4.13%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.14B5.54%
----
----
EPS
-0.35764.13%
----
----

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly